From new surgical techniques and treatments to studies on neurodegenerative disease, here are five of the top brain science stories from this year. In the progression of Alzheimer's disease a ...

Study to assess ability of GAL-101 eye drops in slowing or stopping the growth of geographic atrophy, a severe form of age-related macular ...

Blarcamesine: Potential novel oral treatment to target upstream Alzheimer's disease pathology through autophagy enhancement Submission based on favorable ANAVEX®2-73-AD-004 trial results in patients ...

On December 9, 2024, Anavex announced its upcoming presentation of topline long-term data from the Phase IIb/III ATTENTION-AD Open-Label-Extension (OLE) trial at the J.P. Morgan 2025 Healthcare ...

Blarcamesine is an orally once daily administered small molecule for the potential treatment of patients with Alzheimer's disease.